Wockhardt posts net loss of 177 crore in Q4; antibiotic products make progress
Wockhardt's total income for the last quarter under review was 754 crore, from 710 crore in the same period last year29-05-2024
29-05-2024
WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Pursuant to Regulation 30 of SEBI(Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 28th May 2024 approved the the Appointment of M/s. M S K C & Associates, Chartered Accountant as Statutory Auditors o the Company for a period of 5 years with effect from conclusion of forthcoming Annual General Meeting.28-05-2024
WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Submission pursuant to Regulation 30 of Listing Regulations on Audited Financial Results (standalone & consolidated) for quarter and financial year ended 31st March, 202428-05-2024
WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of Listing Regulations-Press release Zidebactam/Cefepime WCK 5222 update.28-05-2024
WOCKHARDT LTD. - 532300 - Outcome Of The Board Meeting Held On May 28, 2024
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, We wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. May, 28, 2024 have approved the matters as attached in the PDF.28-05-2024
WOCKHARDT LTD. - 532300 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI(Listing Obligations and Disclosure Requirements) Regulations 2015 ; please find enclose herewith the Annual Secretarial Compliance Report for the year ended 31st March, 2024 .28-05-2024
WOCKHARDT LTD. - 532300 - Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited
WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, 28th May, 2024, inter-alia, to consider and approve the following: (i) the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended 31st March, 2024; and (ii) raising of funds by various methods as may be permitted under applicable law, subject to consent of shareholder at the ensuing Annual General Meeting and such approvals and compliances as may be required, and to approve ancillary actions for the above mentioned fund raising.21-05-2024
WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Credit Rating
This is to inform you that ICRA Limited(ICRA) has assigned a long term rating of [ICRA]BBB-Stable and short-term rating of [ICRA]A3 for the Company, [ICRA]BBB-(Stable) for long term Fund Based Term Loan of Rs. 75 Cr, [ICRA]BBB-(Stable)/[ICRA]A3 for long term/short term fund based Working Capital limits of Rs. 512.80 Cr, Long term/short term -Non Fund Based limits of Rs. 171.20 Cr, and long term/short term -Unallocated limits of Rs. 326 Crore with "Stable" outlook. This is an Investment Grade Rating.16-05-2024
WOCKHARDT LTD. - 532300 - Statement On Deviation Or Variation Of Funds Raised Through Qualified Institutions Placement For The Quarter Ended 31St March, 2024
Please find the Statement on Deviation or Variation of funds raised through QIP for the quarter ended 31st March, 2024. We hereby confirm that there has been no deviation in the utilization of issue proceeds from the objects as stated in the Placement Document dated 26th March, 2024 for QIP.15-05-2024